Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary shares, par value $0.000174
- Total 13F shares
- 1,288
- Total 13F value
- $3,632
- Share change
- -294
- SEC-reported price per share
- $2.82
- Number of holders
- 1
- Value change
- -$829
- Number of sells
- 1
- Shares outstanding
- 62,516,710
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
1
Top holders
1
CNTB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Ownership snapshot
Top reported holders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Panacea Innovation Ltd
Disclosed value leader
Panacea Innovation Ltd
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 25%
13D/G row: Panacea Innovation Ltd
Showing 1-6 of 15 holder rows.
Quick read
Panacea Innovation Ltd leads the comparable SEC ownership view at 25%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Panacea Innovation Ltd's linked filing trail.
Comparable ownership
Top 5
Panacea Innovation Ltd
25%
Ikarian Capital, LLC
8.8%
BML Capital Management, LLC
2%
RENAISSANCE TECHNOLOGIES LLC
0.25%
MARSHALL WACE, LLP
0.09%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
Panacea Innovation Limited
|
25%
|
$13,950,000
13,950,000 shares
|
$0 | 21 Jul 2025 |
| Ikarian Capital, LLC |
13D/G
|
8.8%
|
$13,910,809
4,933,086 shares
|
$0 | 31 Dec 2025 |
| BML Capital Management, LLC |
13F
Company
|
2%
|
$1,913,925
1,267,500 shares
|
— | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.25%
|
$238,882
158,200 shares
|
— | 30 Sep 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.09%
|
$85,886
58,031 shares
|
— | 30 Sep 2025 |
| Koa Wealth Management, LLC |
13F
Company
|
0.08%
|
$74,896
49,600 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1,288
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2025 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend